Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move: #Oklahoma, #Australia
and Continued Cannabis Stigmas
Delta, Kelowna, BC, March 9th, 2023
(Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site
release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/030923-Cannabis.mp3
Read
this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/03091Oklahoma-Australia.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we look at Oklahoma’s
rejection of recreational cannabis, roadside testing in Australia and the
issues surrounding roadside testing in legal cannabis jurisdictions and the
continued use of outdated cannabis stigmas
In recent news, Oklahoma rejected a new ballot
intended to bring recreational cannabis to the state. The state, which
currently has a growing medical cannabis industry, rejected the recent ballot
question that would have allowed dispensaries across the state to sell cannabis
to anyone over the age of 21.
The proposal was widely opposed by law enforcement, school
administrators, and political and faith leaders.
About 10% of the adult population now has a
medical licence, but the programme has been plagued by illegal growers,
headline-grabbing crimes and a deluge of out-of-state consumers.
Pat McFerron, an advisor to the No 820
campaign, said the vote "sends a clear message that Oklahomans oppose the
unfettered access to marijuana we have experienced under our so-called medical
programme".
"Oklahoma is a law and order
state," added Governor Kevin Stitt, a Republican who also opposed the
measure. He vowed to "continue to hold bad actors accountable and crack
down on illegal marijuana operations".
“Today’s decision in Oklahoma is
heartbreaking, especially considering how many challenges this bill faced
before it got to the ballot and how much work advocates put in,” said Jeffrey
M. Zucker, co-founder and president of Denver-based cannabis consultancy Green
Lion Partners and vice chair of the board at the Marijuana Policy Project, a
national legalisation advocacy group.
“We have a long way to go to undo the
damage of the war on drugs, especially in a state where more than 4,500 people
are arrested annually for cannabis possession,” he added.
Last November, similar cannabis referendums
were approved in Maryland and Missouri, but defeated in Arkansas, North Dakota
and South Dakota.
In other news coming from Australia, Victoria’s
drug-driving laws are set to be overhauled for medicinal cannabis users, with
both major parties backing a push by Legalise Cannabis over the “unfair” rules.
Debate on the Road Safety Amendment
(Medicinal Cannabis) bill, introduced by the newly elected Legalise Cannabis
MPs, was adjourned on Wednesday after the government committed to addressing
the issue within months.
The bill seeks to change the state’s road
safety laws to treat medicinal cannabis like other prescription medications for
drivers. Currently, it is an offence for a person to drive with any trace of
tetrahydrocannabinol (THC) in their system, even if they have a prescription
from their doctor.
The Labor MP Harriet Shing, who is a member
of the medicinal cannabis and safe driving working group established by the
government, said finding a “distinction between presence [of THC] and impairment”
was a “significant priority”.
“This work has been going on for a number
of years now. The working group has actually discussed at length the
complexities of this matter and the options and opportunities that might be
available,” she told the upper house on Wednesday.
“We need … to find a way through all of
this so that all drivers are able to be safe on our roads and so that we can
provide those medical supports that Victorians need and indeed deserve.”
The opposition leader in the upper house, Matt
Bach, said the Coalition viewed the current system as “unfair” and
“inconsistent” for 65,000 Victorians currently prescribed medicinal cannabis.
This has been an issue raised in many US
states with medical programs as well as in Canada since federal legislation.
One of the key issues being looked at in all areas is the specifics surrounding
roadside testing and accuracy of the various
equipment being used, how THC is absorbed in the body and the length of time it
stays in your system and the fact that this is a medical product prescribed for a variety of medical
conditions, some of which are necessary for work, unlike alcohol or
other drugs which are tested for on the road.
Finally we look at the continued use of
either unfounded or outdated cannabis stigmas in a variety of news outlets and
how these so called “news stories” continue to avoid much more serious issues
caused by alcohol use, tobacco use, refined sugars and traditional
pharmaceutical medications.
It takes only a brief search on any search
platform, most notoriously Google, to find a variety of news articles and
seudo-studies discussing the dangers of cannabis use, the unknowns of cannabis
use, outdated stigmas and anti-cannabis propaganda.
Typing just simply “cannabis” into Google’s
search engine today brings up the following articles to list just a few.:
●
“Long-Term Cannabis Use, Cognitive Decline, and the
Hippocampus” from Psychology Today, an article which implies a direct
correlation between cannabis use and cognitive decline, but also offers none of
the original data, underplays the fact that most of this data is obtained from
interviews and does not include the cross reference data from the control
groups.
●
“National Survey Reveals More Than One-Third of U.S. Women
Consume Cannabis, But Stigmas Linger” from the Financial Post, which
openly discusses how even though a large percentage of women admit to cannabis
use privately, social stigmas keep them from admitting this openly, especially
when looking at mothers.
●
“Rise in people using cannabis to treat health conditions
- but doctors warn patients are putting themselves at risk” from Sky
News, which discusses how as more people continue to use cannabis in the UK,
doctors warn users of the risks of illicit cannabis, even though while cannabis
users can admit themselves to the hospital, for a
supposed cannabis overdose, there have been no reported overdoses of cannabis,
a drug which has been connected to human culture for thousands of years
If you’re looking for articles which show
much more realistic studies that have been conducted both long term and short
term and have a much larger study group to go off of and discuss the vast
potential of cannabis in reducing opioid addiction and overdoses, alcoholism,
as well as anxiety, inflammation and depression, you have to go to cannabis
devoted news sources like MJBizDaily, Marijuana Moment and Herb, to name a few.
It would be easy to argue there are biases
on both sides of the argument, but the difference is the fear mongering
surrounding cannabis is widely, if not entirely, unfounded. The criticism of
pharmaceutical products like prescription opioids, which in 2021 had 16,706
deaths reported, alcohol, which is linked to more than 140,000 people
(approximately 97,000 men and 43,000 women) deaths from alcohol-related causes
annually, or refined sugars, specifically in beverages produced by companies
such as Coca Cola and Pepsi, which a New Harvard School of Public Health (HSPH)
research suggests that roughly 180,000 obesity-related deaths
worldwide—including 25,000 Americans—are associated with the consumption of sugary
drinks.
When compared to cannabis, which actually
has more data that suggests that cannabis use appears to prevent approximately
17,400 to 38,500 premature deaths annually under current policies and an
estimated 23,500 to 47,500 deaths which could be prevented annually if medical
marijuana were legal nationwide.
This factual reality can seem impossible to
believe when you consider that both alcohol, pharmaceutical products, some of
which are being recommended for off-label use such as the recent news surrounding Ozempic, and
refined sugar products are all allowed to be advertised nationally, if not
globally, including on programming which minors can view, and are endorsed by
government officials and regulatory bodies such as the FDA and CDC.
When looking at these facts and the
transparent hypocrisy surrounding cannabis when compared to other openly legal
substances, it's hard not to ask yourself, what are our world government’s
smoking? It certainly isn’t weed.
Investor ideas reminds all listeners to
read our disclaimers and disclosures on the Investorideas.com website and that
this podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
To
hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
About
Investorideas.com - Big Investing Ideas
We publish breaking
stock news, stock research, guest posts and create original top rated investing
podcasts, plus sector tag articles featuring up and coming companies and
industry leaders. Investor Idea’s
original branded content includes the Crypto
Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock
directories for AI and tech, biotech, cannabis, cleantech, crypto, defense,
gaming, health and wellness, mining, oil and gas, sports and water.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of
each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except
where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook
https://www.facebook.com/Investorideas
Follow us on YouTube
https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
